Navigation Links
ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
Date:6/3/2008

lth applications.

About ViroDefense Inc

ViroDefense Inc is an antiviral research, development and consulting company that advocates for and facilitates development of effective antiviral pharmaceuticals that address global public health threats. ViroDefense Inc is presently focused on development of antiviral drugs for poliomyelitis. Currently, there are no poliovirus antiviral drug products available. ViroDefense INC has offices in the Rockville Innovation Center, located in Rockville, MD, part of the Montgomery County Department of Economic Development's Business Innovation Network.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE ViroDefense Inc
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
2. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
3. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
4. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
5. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
6. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
7. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
8. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
9. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
10. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
11. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), a technology ... solutions for the clinical trials industry, today ... eClinical Software. This release advances the ... delivery and introduces two new mechanisms for ... Learning Center(TM) and the DATATRAK Learning Manager(TM). ...
(Date:12/16/2009)... Dec. 16 Hospira, Inc. (NYSE: ... delivery company, today announced that it will host a ... results and projections for 2010 on Thursday, Feb. 4, ... will release its fourth-quarter and full-year 2009 results earlier ... the conference call. ,, A live webcast of the ...
(Date:12/16/2009)... 16 EuroPharma, Inc. signs exclusive ... use of super absorbency BCM-95® curcumin and ... The exclusive distribution territory for these ... store channel and professional channel, which includes ... BCM-95® is a highly absorbable curcumin. ...
Breaking Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 1Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 2Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 3Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 4KATE AND CASSIE CARE 21 This Harvest Season Charity Reaps the Benefits of Kate 26 Cassie wines 57888 1KATE AND CASSIE CARE 21 This Harvest Season Charity Reaps the Benefits of Kate 26 Cassie wines 57888 2
... Phase 2 Colorectal and Prostate Trials -- Company to ... Experts - SOUTH SAN FRANCISCO, Calif., May 4 ... announced that the Company will present new data from ... Company,s lead product candidate, at poster sessions during the ...
... Submits sNDA for NEXIUM Capsules for Risk Reduction of ... 4 AstraZeneca (NYSE: AZN ) today ... to the U.S. Food and Drug Administration (FDA) seeking ... esomeprazole magnesium for the risk reduction of low dose ...
Other Medicine Technology:Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 2Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 3Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 4AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 2AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 3AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 4
(Date:12/16/2009)... of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 million ... included in the final Fiscal Year 2010 Defense Appropriations ... research cancers, like colorectal cancer, that are not addressed ... programs run by the U.S. Army Medical Research and ... funding for this new cancer research program was included ...
(Date:12/16/2009)... is long-term goal, researchers say , , WEDNESDAY, Dec. ... to predict whether a patient will suffer a second ... "This is an important new tool because studies have ... after a first stroke are more likely to die ... General Hospital and Harvard Medical School, said in an ...
(Date:12/16/2009)... plays a role in reducing inflammation in the lungs ... variant that plays a role in inflammation seems to ... as adults who smoke. , Researchers also found that ... had a lower risk of developing chronic obstructive pulmonary ... smoking. , "The gene seems to be protective of ...
(Date:12/16/2009)... health and environmental concerns about the emerging nanotechnology industry, ... behavior of nanoparticles in municipal sewage treatment plants ... published in ACS, journal Environmental Science & Technology ... Ecology and Hydrology and colleagues note that experts predict ... less than 1/1000th the width of a human hair ...
(Date:12/16/2009)... commonly found in fatty fish and algae help ... by the American Psychological Association. The finding connects ... people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit hyperactivity ... nervous system. , The study, reported in ... evidence that fish is brain food. The key ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:Behavior modification could ease concerns about nanoparticles 2Health News:New study links DHA type of omega-3 to better nervous-system function 2
... retinopathy who were destined to go blind within five ... treatment with Avastin , a well-known cancer drug, according ... Archives of Ophthalmology. ,This is a major breakthrough ... therapy and commonly develop radiation retinopathy, said Paul T. ...
... where the potentially lethal H5N1 strain of bird flu was ... ,"All the turkeys on the farm have been ... in the area, around 1,000 birds in all," Czech veterinary ... completed today (Friday)," he added. ,The H5N1 strain of ...
... people in Vietnam in the first six months of the ... period last year, the health ministry said Friday. ... 15 percent rise to 19,144 new infections from the mosquito-borne ... delta. ,Malaysia and other Southeast Asian countries have ...
... have formed a new compound AN2690, that might help ... an enzyme crucial for the protein synthesis of fungal ... team of researchers including Dickon Alley and Stephen Cusack ... Biology Laboratory (EMBL) outstation in Grenoble, France. ,AN2690 ...
... an Anglo-American company has been allowed to store white ... by the US Food and Drug Administration. ... immune system that defend the body against both infectious ... take 480-millilitre of blood from interested healthy individuals and ...
... environmental group Friday welcomed the European Union (EU) Parliament's resolution ... the Indian government to do likewise. ,Toxics ... Wednesday. ,The group had called upon governments across ... United Nations Environment Programme (UNEP) in February. ...
Other Medicine News:Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Researchers Devise New Compound to Treat Fungal Infections 2
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... large sequencing gels or multiple smaller gels. Rugged design ... lasting durability and corrosion resistance., Large 40 x ... Drying Rate - large sequence gels can be dried ... of temperature and time , Cool-down ...
Inquire...
... and safely, the Hoefer GD 2000 uses a ... beneath the gel through a heavy aluminum platen. ... to 33 x 44 cm in as little ... even heat distribution and even vacuum distribution under ...
Medicine Products: